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ABSTRACT
Cutaneous metastasis from a carcinoma is a relatively uncommon phenomenon. Prompt diagnosis is crucial, as it will have future implications, 
particularly regarding prognosis and treatment. Skin metastases can be suspected and recognized earlier through physical examination 
than metastases in other organs or systems. However, they can be a diagnostic challenge due to the variable clinical presentation. This case 
highlights the importance of having a high index of suspicion for cutaneous metastases, especially in patients with a previous history of 
cancer.
LEARNING POINTS
• Cutaneous metastases occur in approximately 0.7–10% of patients with invasive carcinomas and, when present, usually indicate an 
unfavourable outcome. 
• Clinically, cutaneous metastasis can pose a diagnostic challenge and a high index of suspicion is mandatory for a prompt diagnosis.
•	 Skin	biopsy	of	such	lesions	is	important	to	confirm	the	diagnosis	and,	in	the	right	clinical	scenario,	they	can	provide	information	on	the	
primary origin of the tumour. 
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INTRODUCTION
Cutaneous	metastases	are	defined	as	neoplastic	lesions	affecting	the	dermis	or	the	subcutaneous	tissue	that	originate	from	another	primary	
malignancy. They are a relatively uncommon phenomenon with a reported incidence in the literature ranging from 0.7% to 10% [1,2]. Once 
diagnosed, cutaneous metastases indicate a poor clinical outcome as they are related to a higher stage, later course and/or an unsuccessful 
response to treatment[1–4].
Compared with metastases in other organs or systems, skin metastases can be suspected and promptly recognized by a clinician through 
physical examination[4]. However, the clinical presentation can be a diagnostic challenge as the lesions are frequently asymptomatic and may 
present	in	variable	forms	such	as	papules,	nodules,	plaques,	or	inflammatory	and	bullous	lesions[1,5–7]. Skin biopsy evaluation of such lesions 
is fundamental as it can provide information on the primary origin of the tumour[4, 8]. 
CASE REPORT
A 52-year-old Caucasian woman was seen in our outpatient clinic for the recent appearance over the previous 6 months of numerous 
asymptomatic skin lesions on the neck, trunk and proximal regions of the upper and lower limbs. Her medical history included a diagnosis of 
right-sided invasive lobular breast carcinoma (cT3N+, oestrogen and progesterone receptor positive, ERBB2 negative) 9 years earlier. She 
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had undergone neoadjuvant chemotherapy and a right radical mastectomy followed by local radiotherapy, adjuvant chemotherapy and 5 
years of endocrine therapy with tamoxifen. 
In the past 2 years, stage IV breast cancer with multifocal metastatic bone disease had been documented. Letrozole therapy was given 
initially, with partial response, but during the previous year there had been continuing on-going symptomatic bone involvement. The patient 
had declined further medical treatment and initiated alternative therapies, namely ozonotherapy. On physical examination, multiple skin-
coloured to brown papules were seen on the neck, trunk, arms and thighs (Fig. 1).	A	punch	biopsy	was	performed	and	confirmed	the	diagnosis	
of	cutaneous	infiltration	by	neoplastic	cells,	compatible	with	metastatic	lobular	carcinoma	of	the	breast	(Fig. 2). 
Figure 1. Multiple skin-coloured to brown papules on (A) the upper chest and (B) the upper back
Figure 2. (A) Epithelial cells infiltrate the superficial and reticular dermis. 
(B) The tumour cells show moderate nuclear atypia and scant eosinophilic 
cytoplasm. (C) Positive nuclear staining for oestrogen receptors in the 
neoplastic cells
DISCUSSION
Cutaneous metastases occur in approximately 0.7–10% of patients with invasive carcinomas. Although uncommon, and comprising 
approximately 2% of all skin tumours, when present they usually predict a poor prognosis[5]. These skin manifestations are usually seen 
in patients with advanced disease, but they can be the presenting sign of a neoplastic disorder in 12% of the patients[7]. According to the 
literature,	skin	metastasis	can	be	the	first	sign	of	metastatic	involvement,	particularly	in	breast	cancer	(in	23.9%	of	patients)	and	melanoma[1,8]. 
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El Khoury et al. reported that in these patients, the most common primary origin was breast carcinoma in women and laryngeal carcinoma 
in men[9].
With an aging population and increases in the average life expectancy and the incidence of cancer, the global burden of cancer is expected 
to grow. It is therefore important for clinicians and pathologists to be aware of the clinical spectrum of cutaneous metastases, and to have 
a high index of suspicion for early diagnosis and prompt management[5,7].	Gan	et	al.	reported	that	in	a	cohort	of	35	patients	with	confirmed	
cutaneous metastases, the diagnosis was suspected in 72% (n=25), based on clinical features (46%, n=16) or the presence of active metastatic 
disease elsewhere (26%, n=9)[5]. Accurate recognition of cutaneous metastases on biopsy examination is also crucial. In cases of an unknown 
primary tumour, histological and immunohistochemical evaluation is important to guide clinical and imaging investigations. Moreover, in 
cases of a previously documented tumour, cutaneous metastases may upstage the tumour and change the prognosis[4].
In summary, the presented clinical case highlights the importance of early assessment of patients with cutaneous lesions, especially if there 
is a previous history of cancer, regardless of stage of treatment. This may lead to the prompt diagnosis of cutaneous metastases, which will 
have future implications, particularly regarding clinical outcome and treatment options. 
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